Author:
Xiong Yu,Mouginot Manon,Reppel Loic,Qian Chongsheng,Stoltz Jean-francois,Bensoussan Danièle,Decot Véronique
Funder
China Scholarship Council
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Liu YC, Chien SH, Fan NW, Hu MH, Gau JP, Liu CJ, et al. Prognostic factors on the graft-versus-host disease-free and relapse-free survival after adult allogeneic hematopoietic stem cell transplantation. Stem Cells Int. 2016;2016:5143071.
2. Bar M, et al. Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant. 2013;19(6):949–57.
3. Kolb HJ, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 1990;76(12):2462–5.
4. Costa-Garcia M, Vera A, Moraru M, Vilches C, López-Botet M, Muntasell A, et al. Antibody-mediated response of NKG2Cbright NK cells against human cytomegalovirus. J Immunol Baltim Md 1950. 2015;194(6):2715–24.
5. Haen SP, et al. Prognostic relevance of HER2/neu in acute lymphoblastic leukemia and induction of NK cell reactivity against primary ALL blasts by trastuzumab. Oncotarget. 2016;7(11):13013–30.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献